NewsNovo
Ares Capital Corporation (ARCC) won stockholder approval on August 13, 2026 to sell or issue common stock at prices below its then-current net asset value per share.
The authorization gives management a capital-raising lever it can pull for the next twelve months. What complicates it is the size of the dissent: 70,093,164 votes against, alongside 14,771,898 abstentions.
The special meeting drew votes against a record-date share count of 718,022,845 shares of common stock outstanding as of May 15, 2026.
The company's common stock trades on the NASDAQ Global Select Market under the ticker ARCC. The FOR tally from all stockholders reached 287,240,274.
Keep reading